Literature DB >> 11380226

Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation.

A Katz1, T A Buchholz, H Thames, C D Smith, M D McNeese, R Theriault, S E Singletary, E A Strom.   

Abstract

PURPOSE: Postmastectomy irradiation improves overall survival for breast cancer patients at high risk for locoregional recurrence (LRR). The objective of this study was to use recursive partitioning analysis (RPA) to define patient subgroups at high risk for LRR following mastectomy. PATIENTS AND METHODS: A cohort of 1031 patients treated on prospective trials with mastectomy and doxorubicin-based chemotherapy without irradiation was analyzed. The variables considered in the RPA were tumor size, number of involved nodes, number of nodes examined, and percentage of nodes involved (nodes involved/nodes examined). The endpoint was LRR +/- distant metastasis. Only patients with complete data were analyzed (n = 913). Median follow-up was 8 years (range, 0.7-22 years).
RESULTS: Involvement of 20% or more of the lymph nodes examined was the most significant variable predicting LRR. Three risk categories were defined. Patients with 20% or more involved nodes and tumors of 3.5 cm or more were at greatest risk for LRR (41% at 8 years). An intermediate-risk group included patients with 20% or more involved nodes and tumors of less than 3.5 cm as well as those with less than 20% involved nodes and tumor size of 5 cm or greater (18% at 8 years). Patients with less than 20% involved nodes and tumor size of less than 5 cm were at lowest risk for LRR (10% at 8 years).
CONCLUSION: Tumor size and extent of nodal involvement play interrelated roles in predicting LRR following mastectomy and systemic therapy. Patients with 20% or greater involved nodes and those with less than 20% nodes and tumors of 5.0 cm or greater are at significant risk of LRR and should be considered for postoperative irradiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380226     DOI: 10.1016/s0360-3016(01)01465-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients.

Authors:  Emin Yildirim; Ugur Berberoglu
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

Review 2.  Postmastectomy radiotherapy in women with breast cancer metastatic to one to three axillary lymph nodes.

Authors:  C I Sartor
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

3.  Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and doxorubicin-based chemotherapy for breast cancer.

Authors:  Jay P Reddy; Larry Levy; Julia L Oh; Eric A Strom; George H Perkins; Thomas A Buchholz; Wendy A Woodward
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-16       Impact factor: 7.038

4.  Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival.

Authors:  Wendy A Woodward; Pauline T Truong; Tse-Kuan Yu; Welela Tereffe; Julia Oh; George Perkins; Eric Strom; Funda Meric-Bernstam; Ana-Maria Gonzalez-Angulo; Caroline Speers; Joseph Ragaz; Thomas A Buchholz
Journal:  Breast Cancer Res Treat       Date:  2010-03-20       Impact factor: 4.872

5.  Post Mastectomy Radiation for Stage II Breast Cancer Patients with T1/T2 Lesions.

Authors:  Shai Libson; Eduardo Perez; Christiane Takita; Eli Avisar
Journal:  Eur J Breast Health       Date:  2019-04-01

6.  Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1-3 Axillary Lymph Node(s) Metastasis.

Authors:  Nüvit Duraker; Bakır Batı; Davut Demir; Zeynep Civelek Caynak
Journal:  ISRN Oncol       Date:  2011-10-12

7.  Using nodal ratios to predict risk of regional recurrences in patients treated with breast conservation therapy with 4 or more positive lymph nodes.

Authors:  William Castrucci; Donald Lannin; Bruce G Haffty; Susan A Higgins; Meena S Moran
Journal:  ISRN Surg       Date:  2011-06-30

8.  Ratios of involved nodes in early breast cancer.

Authors:  Vincent Vinh-Hung; Claire Verschraegen; Donald I Promish; Gábor Cserni; Jan Van de Steene; Patricia Tai; Georges Vlastos; Mia Voordeckers; Guy Storme; Melanie Royce
Journal:  Breast Cancer Res       Date:  2004-10-06       Impact factor: 6.466

9.  Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes.

Authors:  S I Kim; S-H Cho; J S Lee; H-G Moon; W C Noh; H J Youn; B K Ko; B-W Park
Journal:  Br J Cancer       Date:  2013-08-13       Impact factor: 7.640

10.  Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran.

Authors:  Abbas Rezaianzadeh; Janet Peacock; Daniel Reidpath; Abdolrasoul Talei; Seyed Vahid Hosseini; Davood Mehrabani
Journal:  BMC Cancer       Date:  2009-06-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.